StockCIK 1323885
AtriCure, Inc. (ATRC): Insider Trades and Fund Holdings
In the past 12 months, AtriCure, Inc. insiders reported 0 open-market purchases worth $0 and 5 sales worth $1.63M; 3 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$1.63MSold by insiders, 12 months
2Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 24, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 24 | Salvatore PriviteraChief Technical Officer | ▼ SELL10b5-1 | $271K |
| Sep 14 | Regina E. GrovesDirector | ▼ SELL | $288K |
| Sep 10 | Salvatore PriviteraChief Technical Officer | ▼ SELL10b5-1 | $201K |
| Sep 4 | Salvatore PriviteraChief Technical Officer | ▼ SELL10b5-1 | $408K |
| Aug 26 | Karl S. DahlquistGeneral Counsel | ▼ SELL | $458K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Salvatore Privitera | Chief Technical Officer | 0 | $0 | 3 | $880K |
| Regina E. Groves | Director | 0 | $0 | 1 | $288K |
| Karl S. Dahlquist | General Counsel | 0 | $0 | 1 | $458K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report ATRC
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 234,100 | $6.55M | ▼ −24.2% |
| Bridgewater Associates | 76,307 | $2.14M | ▲ +127.7% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →